Regional
MEP (Medical Emergency Partnership) in partnership with SSM Health
MEP (Medical Emergency Partnership) in partnership with SSM Health (WI) carries 48 drugs across 206 dose entries in its current published protocol, effective 2026-04-01.
Drugs and doses48
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 15 mg/kg (max 1000 mg) | IV/PO | not captured | standing | page 128 |
| Fever | peds | 15 mg/kg (max 1000 mg) | IV/PO | not captured | standing | page 128 |
| Other | adult | 15 mg/kg (max 1000 mg) | IV/PO | not captured | standing | page 128 |
| Other | peds | 15 mg/kg (max 1000 mg) | IV/PO | not captured | standing | page 128 |
| Mild to moderate pain | adult | 15 mg/kg (max 1000 mg) | IV/PO | not captured | standing | page 128 |
| Mild to moderate pain | peds | 15 mg/kg (max 1000 mg) | IV/PO | not captured | standing | page 128 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 0.2 mg/kg (max 12 mg) | IV/IO | not captured | standing | page 129 |
| Narrow-complex tachycardia | peds | 0.2 mg/kg (max 12 mg) | IV/IO | not captured | standing | page 129 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mg | NEB/MDI | not captured | standing | page 130 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB/MDI | not captured | standing | page 130 |
| Hyperkalemia | adult | 10 mg | NEB | not captured | standing | page 130 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 5 mg/kg (max 300 mg) | IV/IO | not captured | standing | page 131 |
| Cardiac arrest | peds | 5 mg/kg (max 300 mg) | IV/IO | not captured | standing | page 131 |
| Narrow-complex tachycardia | adult | 5 mg/kg (max 150 mg) | IV/IO | not captured | standing | page 131 |
| Narrow-complex tachycardia | peds | 5 mg/kg (max 150 mg) | IV/IO | not captured | standing | page 131 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 132 |
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 132 |
| STEMI | adult | 324 mg | PO | not captured | standing | page 132 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 0.02 mg/kg (max 1 mg) | IV/IO | not captured | standing | page 133 |
| Bradycardia | peds | 0.02 mg/kg (max 1 mg) | IV/IO | not captured | standing | page 133 |
| Organophosphate poisoning | adult | 2 mg | IV/IO/IM | not captured | standing | page 133 |
| Organophosphate poisoning | peds | 2 mg | IV/IO/IM | not captured | standing | page 133 |
Buprenorphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 16 mg | SL | not captured | standing | page 135 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 20 mg/kg | IV/IO | not captured | standing | page 36 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 20 mg/kg | IV/IO | not captured | standing | page 36 |
| Bradycardia | adult | 20 mg/kg | IV/IO | not captured | standing | page 35 |
| Bradycardia | peds | 20 mg/kg | IV/IO | not captured | standing | page 35 |
| Cardiac arrest | adult | 20 mg/kg | IV/IO | not captured | standing | page 36 |
| Cardiac arrest | peds | 20 mg/kg | IV/IO | not captured | standing | page 36 |
| Other | adult | 20 mg/kg | IV/IO | not captured | standing | page 134 |
| Other | peds | 20 mg/kg | IV/IO | not captured | standing | page 134 |
| Narrow-complex tachycardia | adult | 20 mg/kg | IV/IO | not captured | standing | page 41 |
| Narrow-complex tachycardia | peds | 20 mg/kg | IV/IO | not captured | standing | page 41 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 60 mg/kg | IV/IO | not captured | standing | page 36 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 60 mg/kg | IV/IO | not captured | standing | page 36 |
| Bradycardia | adult | 60 mg/kg | IV/IO | not captured | standing | page 35 |
| Bradycardia | peds | 60 mg/kg | IV/IO | not captured | standing | page 35 |
| Cardiac arrest | adult | 100 mg/kg | IV/IO | not captured | standing | page 36 |
| Cardiac arrest | peds | 100 mg/kg | IV/IO | not captured | standing | page 36 |
| Other | adult | 60 mg/kg | IV/IO | not captured | standing | page 134 |
| Other | peds | 60 mg/kg | IV/IO | not captured | standing | page 134 |
| Narrow-complex tachycardia | adult | 60 mg/kg | IV/IO | not captured | standing | page 41 |
| Narrow-complex tachycardia | peds | 60 mg/kg | IV/IO | not captured | standing | page 41 |
Cefazolin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 35 mg/kg | IV/IO | not captured | standing | page 72 |
| Trauma / hemorrhage | peds | 35 mg/kg | IV/IO | not captured | standing | page 72 |
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.6 mg/kg | IV/IO/PO | not captured | standing | page 51 |
| Anaphylaxis | peds | 0.6 mg/kg | IV/IO/PO | not captured | standing | page 51 |
| Croup | adult | 0.6 mg/kg | IV/IO/PO | not captured | standing | page 40 |
| Croup | peds | 0.6 mg/kg | IV/IO/PO | not captured | standing | page 40 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 3 mL/kg | IV/IO | not captured | standing | page 61 |
| Hypoglycemia | peds | 3 mL/kg | IV/IO | not captured | standing | page 61 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 0.25 mg/kg | IV/IO | not captured | standing | page 41 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 1 mg/kg (max 50 mg) | IV/IO/IM/PO | not captured | standing | page 143 |
| Allergic reaction | peds | 1 mg/kg (max 50 mg) | IV/IO/IM/PO | not captured | standing | page 143 |
| Dystonic reaction | adult | 1 mg/kg (max 50 mg) | IV/IO/IM/PO | not captured | standing | page 143 |
| Dystonic reaction | peds | 1 mg/kg (max 50 mg) | IV/IO/IM/PO | not captured | standing | page 143 |
| Other | adult | 1 mg/kg (max 50 mg) | IV/IO/IM | not captured | standing | page 134 |
| Other | peds | 1 mg/kg (max 50 mg) | IV/IO/IM | not captured | standing | page 134 |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 0.1 mg/kg (max 5 mg) | IV/IO | not captured | standing | page 53 |
| Agitation | adult | 0.2 mg/kg (max 10 mg) | IM | not captured | standing | page 53 |
| Nausea / vomiting | adult | 0.625 mg | IV/IO | not captured | standing | page 144 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | page 51 |
| Anaphylaxis | peds | 0.15–0.3 mg | IM | not captured | standing | page 51 |
| Asthma / bronchospasm | adult | 0.3–0.5 mg | IM | not captured | standing | page 40 |
| Asthma / bronchospasm | peds | 0.15–0.3 mg | IM | not captured | standing | page 40 |
| Bradycardia | adult | 2–12 mcg | IV/IO | not captured | standing | page 35 |
| Bradycardia | peds | 0.01 mg/kg (max 1 mg) | IV/IO | not captured | standing | page 35 |
| Cardiac arrest | adult | 0.01 mg/kg (max 1 mg) | IV/IO | not captured | standing | page 35 |
| Cardiac arrest | peds | 0.01 mg/kg (max 1 mg) | IV/IO | not captured | standing | page 35 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.3 mg/kg (max 30 mg) | IV/IO | not captured | standing | page 34 |
| RSI induction | peds | 0.3 mg/kg (max 30 mg) | IV/IO | not captured | standing | page 34 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.5–1 mcg/kg (max 100 mcg) | IV/IO/IM/IN | not captured | standing | page 39 |
| Mild to moderate pain | peds | 0.5–1 mcg/kg (max 100 mcg) | IV/IO/IM/IN | not captured | standing | page 39 |
| Procedural sedation | adult | 0.5–1 mcg/kg (max 100 mcg) | IV/IO/IM/IN | not captured | standing | page 33 |
| Procedural sedation | peds | 0.5–1 mcg/kg (max 100 mcg) | IV/IO/IM/IN | not captured | standing | page 33 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 0.05 mg/kg (max 2 mg) | IV/IO | not captured | standing | page 36 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 0.05 mg/kg (max 2 mg) | IV/IO | not captured | standing | page 36 |
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | page 61 |
| Hypoglycemia | peds | 0.5 mg | IM | not captured | standing | page 61 |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.02 mg/kg | IV/IO/IM | not captured | standing | page 67 |
| Mild to moderate pain | peds | 0.02 mg/kg | IV/IO/IM | not captured | standing | page 67 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 70 mg/kg | IV/IO | not captured | standing | page 56 |
| Cyanide poisoning | peds | 70 mg/kg | IV/IO | not captured | standing | page 56 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 10 mg/kg | PO | not captured | standing | page 58 |
| Fever | peds | 10 mg/kg | PO | not captured | standing | page 58 |
| Mild to moderate pain | adult | 10 mg/kg | PO | not captured | standing | page 58 |
| Mild to moderate pain | peds | 10 mg/kg | PO | not captured | standing | page 58 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | page 40 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | page 40 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 4 mg/kg | IM | not captured | standing | page 53 |
| Agitation | peds | 4 mg/kg | IM | not captured | standing | page 53 |
| Mild to moderate pain | adult | 0.25 mg/kg | IV/IO/IM/IN | not captured | standing | page 67 |
| Mild to moderate pain | peds | 0.25 mg/kg | IV/IO/IM/IN | not captured | standing | page 67 |
| Procedural sedation | adult | 2 mg/kg | IV/IO | not captured | standing | page 33 |
| Procedural sedation | peds | 2 mg/kg | IV/IO | not captured | standing | page 33 |
| Seizure | adult | 2 mg/kg | IV/IO | not captured | standing | page 68 |
| Seizure | peds | 2 mg/kg | IV/IO | not captured | standing | page 68 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 0.5 mg/kg | IV/IO | not captured | standing | page 58 |
| Fever | adult | 1 mg/kg | IM | not captured | standing | page 58 |
| Fever | peds | 0.5 mg/kg | IV/IO | not captured | standing | page 58 |
| Fever | peds | 1 mg/kg | IM | not captured | standing | page 58 |
| Mild to moderate pain | adult | 0.5 mg/kg | IV/IO | not captured | standing | page 67 |
| Mild to moderate pain | adult | 1 mg/kg | IM | not captured | standing | page 67 |
| Mild to moderate pain | peds | 0.5 mg/kg | IV/IO | not captured | standing | page 67 |
| Mild to moderate pain | peds | 1 mg/kg | IM | not captured | standing | page 67 |
| Sepsis | adult | 0.5 mg/kg | IV/IO | not captured | standing | page 58 |
| Sepsis | adult | 1 mg/kg | IM | not captured | standing | page 58 |
| Sepsis | peds | 0.5 mg/kg | IV/IO | not captured | standing | page 58 |
| Sepsis | peds | 1 mg/kg | IM | not captured | standing | page 58 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 20 mg | IV/IO | not captured | standing | page 47 |
Levetiracetam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Head injury / TBI | adult | 60 mg/kg | IV/IO | not captured | standing | page 72 |
| Head injury / TBI | peds | 60 mg/kg | IV/IO | not captured | standing | page 72 |
| Seizure | adult | 60 mg/kg | IV/IO | not captured | standing | page 68 |
| Seizure | peds | 60 mg/kg | IV/IO | not captured | standing | page 68 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 36 |
| Cardiac arrest | peds | 1.5 mg/kg | IV/IO | not captured | standing | page 36 |
| Mild to moderate pain | adult | 0.5 mg/kg | IO | not captured | standing | page 113 |
| Mild to moderate pain | peds | 0.5 mg/kg | IO | not captured | standing | page 113 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 161 |
| Agitation | adult | 0.2 mg/kg | IM | not captured | standing | page 161 |
| Agitation | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 161 |
| Hyperthermia | adult | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 161 |
| Hyperthermia | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 161 |
| Nausea / vomiting | adult | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 161 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 161 |
| Other | adult | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 161 |
| Other | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 161 |
| Procedural sedation | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 161 |
| Procedural sedation | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 161 |
| Seizure | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 161 |
| Seizure | adult | 0.2 mg/kg | IM | not captured | standing | page 161 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 161 |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | page 161 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 50 mg/kg | IV/IO | not captured | standing | page 40 |
| Asthma / bronchospasm | peds | 50 mg/kg | IV/IO | not captured | standing | page 40 |
| COPD | adult | 50 mg/kg | IV/IO | not captured | standing | page 40 |
| COPD | peds | 50 mg/kg | IV/IO | not captured | standing | page 40 |
| Eclampsia / pre-eclampsia | adult | 10 g | IM | not captured | standing | page 47 |
| Eclampsia / pre-eclampsia | adult | 50 mg/kg | IV/IO | not captured | standing | page 47 |
| Eclampsia / pre-eclampsia | peds | 10 g | IM | not captured | standing | page 47 |
| Eclampsia / pre-eclampsia | peds | 50 mg/kg | IV/IO | not captured | standing | page 47 |
| VF / pulseless VT | adult | 50 mg/kg | IV/IO | not captured | standing | page 36 |
| VF / pulseless VT | peds | 50 mg/kg | IV/IO | not captured | standing | page 36 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 2 mg/kg | IV/IO | not captured | standing | page 163 |
| Allergic reaction | peds | 2 mg/kg | IV/IO | not captured | standing | page 163 |
| Anaphylaxis | adult | 2 mg/kg | IV/IO | not captured | standing | page 163 |
| Anaphylaxis | peds | 2 mg/kg | IV/IO | not captured | standing | page 163 |
| Other | adult | 2 mg/kg | IV/IO | not captured | standing | page 40 |
| Other | peds | 2 mg/kg | IV/IO | not captured | standing | page 40 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 164 |
| Agitation | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 164 |
| Agitation | adult | 0.2 mg/kg | IM/IN | not captured | standing | page 164 |
| Agitation | adult | 0.2 mg/kg | IM/IN | not captured | standing | page 164 |
| Agitation | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 164 |
| Agitation | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 164 |
| Agitation | peds | 0.2 mg/kg | IM/IN | not captured | standing | page 164 |
| Agitation | peds | 0.2 mg/kg | IM/IN | not captured | standing | page 164 |
| Hyperthermia | adult | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 164 |
| Hyperthermia | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 164 |
| Nausea / vomiting | adult | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 164 |
| Nausea / vomiting | adult | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 164 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 164 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 164 |
| Other | adult | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 164 |
| Other | adult | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 164 |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 164 |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN | not captured | standing | page 164 |
| Seizure | adult | 0.1 mg/kg | IV/IO | not captured | standing | page 164 |
| Seizure | adult | 0.2 mg/kg | IM/IN | not captured | standing | page 164 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 164 |
| Seizure | peds | 0.2 mg/kg | IM/IN | not captured | standing | page 164 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4–2 mg | IV/IO/IN | not captured | standing | page 66 |
| Opioid overdose | peds | 0.4–2 mg | IV/IO/IN | not captured | standing | page 66 |
Nerve Agent Antidote Kit
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Organophosphate poisoning | adult | 2.1 mg | IM | not captured | standing | page 66 |
| Organophosphate poisoning | peds | 2.1 mg | IM | not captured | standing | page 66 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 39 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 40 |
Nitrous Oxide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Severe pain | adult | 20-50% concentration | NEB | not captured | standing | page 167 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 4–16 mcg | IV/IO | not captured | standing | page 62 |
Olanzapine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 10 mg | PO | not captured | standing | page 169 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 0.15 mg/kg (max 4 mg) | IV/IO/ODT | not captured | standing | page 170 |
| Nausea / vomiting | peds | 0.15 mg/kg (max 4 mg) | IV/IO/ODT | not captured | standing | page 170 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15 g | PO | not captured | standing | page 61 |
| Hypoglycemia | peds | 15 g | PO | not captured | standing | page 61 |
Oxymetazoline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 spray | IN | not captured | standing | page 172 |
| Other | peds | 2 spray | IN | not captured | standing | page 172 |
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 10 unit | IM | not captured | standing | page 46 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1 mg/kg | IV/IO | not captured | standing | page 34 |
| RSI induction | peds | 1 mg/kg | IV/IO | not captured | standing | page 34 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Crush injury | adult | 1 mEq/kg | IV/IO | not captured | standing | page 72 |
| Crush injury | peds | 1 mEq/kg | IV/IO | not captured | standing | page 72 |
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | standing | page 35 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | page 35 |
| Tricyclic overdose | adult | 1 mEq/kg | IV/IO | not captured | standing | page 36 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | page 36 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 2 mg/kg | IV/IO | not captured | standing | page 34 |
| RSI induction | peds | 2 mg/kg | IV/IO | not captured | standing | page 34 |
Tetracaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 1–2 drop | not captured | not captured | standing | page 72 |
| Mild to moderate pain | peds | 1–2 drop | not captured | not captured | standing | page 72 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 15 mg/kg | IV/IO | not captured | standing | page 46 |
| Other | adult | 500 mg | NEB | not captured | standing | page 59 |
| Other | peds | 250 mg | NEB | not captured | standing | page 59 |
| Trauma / hemorrhage | adult | 30 mg/kg | IV/IO | not captured | standing | page 38 |
| Trauma / hemorrhage | peds | 15 mg/kg | IV/IO | not captured | standing | page 38 |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.1 mg/kg (max 10 mg) | IV/IO | not captured | standing | page 34 |
| RSI induction | peds | 0.1 mg/kg (max 10 mg) | IV/IO | not captured | standing | page 34 |